Lymphoid diagnostic research key publications

  1. Marafioti T, Pozzobon M, Hansmann ML, Pileri SA, Delsol G, Mason DY. Expression of intracellular signaling molecules in classical and lymphocyte predominance Hodgkin disease. Blood, 103: 188-93, 2004.                                               
  2. Marafioti T, Pozzobon M, Hansmann ML, Ventura R, Pileri SA, Roberton H, Gesk S, Gaulard P, Barth TFE, Du MQ, Leoncini L, Moeller P, Natkunam Y, Siebert R, Mason DY. The NFATc1 transcription factor is widely expressed in white cells and translocates from the cytoplasm to the nucleus in a subset of human lymphomas. Br J Haematol, 128:333-42, 2005.
  3. Tedoldi S, Paterson JC, Hansmann ML, Natkunam Y, Ruediger T, Angelisova P, Du MQ, Roberton H, Roncador G, Sanchez L, Pozzobon M, Masir N, Barry R, Pileri S, Mason DY, Marafioti T, Horejsi V. Transmembrane adaptor molecules: A new category of lymphoid cell markers. Blood, 107:213-21, 2006.
  4. Roncador G, Garcia Verdes-Montenegro JF, Tedoldi S, Paterson JC, Klapper W, Ballabio E, Maestre L, Pileri S, Hansmann ML, Piris MA, Mason DY, Marafioti T. Expression of two markers of germinal center T cells (SAP and PD-1) in angioimmunoblastic T-cell lymphoma. Haematologica, 92:1059-66, 2007.       
  5. Marafioti T, Paterson JC, Ballabio E, Reichard KK, Tedoldi S, Hollowood K, Dictor M, Hansmann ML, Pileri SA, Dyer MJ, Sozzani S, Dikic I, Shaw AS, Stein H, Isaacson PG, Facchetti F, Mason DY. Novel molecular markers of normal and neoplastic plasmacytoid dendritic cells. Blood, 111:3778-92; 2008. 
  6. Paterson JC, Ballabio E, Turner SH, Mason DY, Marafioti T. Labeling of multiple cell markers and mRNA using automated apparatus. Appl Immunohistochem Mol Morphol, 16:371-81; 2008.                                                                   
  7. Bacon CM, Paterson JC, Liu H, Payne K, Munson P, Du MQ, Marafioti T. Peripheral T-cell lymphoma with a follicular growth pattern: derivation from follicular helper T cells and relationship to angioimmunoblastic T-cell lymphoma. Br J Haematol, 143:439-41; 2008                                                                                       
  8. Huang Y, Moreau A, Dupuis J, Streubel B, Petit B, Le Gouill S, Martin-Garcia N Copie-Bergman C, Gaillard F, Qubaja M, Fabiani B, Roncador G, Haioun C, Delfau-Larue MH, Marafioti T, Chott A, Gaulard P. Peripheral T-cell lymphomas with a follicular growth pattern are derived from follicular helper T cells (TFH) and may show overlapping features with angioimmunoblastic T-cell lymphomas. Am J Surg Pathol, 30:682-90; 2009.
  9. Rodriguez-Justo M, Attygalle AD, Munson P, Roncador G, Marafioti T, Piris MA. Angioimmunoblastic T-cell lymphoma with hyperplastic germinal centres: a neoplasia with origin in the outer zone of the germinal centre? Clinicopathological and immunohistochemical study of 10 cases with follicular T-cell markers. Mod Pathol 22:753-61; 2009
  10. Pellagatti A, Marafioti T, Paterson JC, Malcovati L, Della Porta MG, Jädersten M, Pushkaran B, George TI, Arber DA, Killick S, Giagounidis A, Hellström-Lindberg E, Cazzola M, Wainscoat JS, Boultwood J. Marked downregulation of the granulopoiesis regulator LEF1 is associated with disease progression in the myelodysplastic syndromes. Br J Haematol 146:86-90; 2009.
  11. Natkunam Y, Tedoldi S, Paterson J, Zhao S, Rodriguez-Justo M, Beck A, Siebert R, Mason DY, Marafioti T. Characterization of c-Maf transcription factor in normal and neoplastic hematolymphoid tissue and its relevance in plasma cell neoplasia. Am J Clin Pathol 132:361-71; 2009
  12. Marafioti T, Paterson JC, Ballabio E, Chott A, Natkunam Y, Rodriguez-Justo M, Plonquet A, Rodriguez-Pinilla SM, Klapper W, Hansmann ML, Pileri SA, Isaacson PG,  Stein H, Piris MA, Mason DY, Gaulard P. The inducible T-cell co-stimulator (ICOS) molecule is expressed on subsets of T-cells and is a new marker of lymphomas of T follicular helper cell derivation. Haematologica Sept 2009 (in press)
  13. Carroll RP, San Segundo Arribas D, Hollowood K, Marafioti T, Clark TG, Harden PN, Wood KJ. Immune phenotype determines risk of developing squamous cell carcinoma after renal transplantation. JASN , Sept 2009 (accepted with minor revision)